| 2.0 |
8.1 |
GO:0010900 |
regulation of phosphatidylcholine catabolic process(GO:0010899) negative regulation of phosphatidylcholine catabolic process(GO:0010900) |
| 0.9 |
2.8 |
GO:0043418 |
cysteine biosynthetic process from serine(GO:0006535) homoserine metabolic process(GO:0009092) cysteine biosynthetic process via cystathionine(GO:0019343) transsulfuration(GO:0019346) homocysteine catabolic process(GO:0043418) |
| 0.9 |
1.7 |
GO:0061188 |
regulation of chromatin silencing at rDNA(GO:0061187) negative regulation of chromatin silencing at rDNA(GO:0061188) |
| 0.8 |
2.4 |
GO:0019695 |
choline metabolic process(GO:0019695) |
| 0.7 |
2.2 |
GO:0035408 |
histone H3-T6 phosphorylation(GO:0035408) |
| 0.7 |
2.2 |
GO:0070544 |
histone H3-K36 demethylation(GO:0070544) |
| 0.7 |
2.2 |
GO:0061298 |
retina vasculature development in camera-type eye(GO:0061298) retina vasculature morphogenesis in camera-type eye(GO:0061299) |
| 0.7 |
3.6 |
GO:0003093 |
regulation of glomerular filtration(GO:0003093) glomerular filtration(GO:0003094) renal filtration(GO:0097205) regulation of renal system process(GO:0098801) |
| 0.7 |
2.1 |
GO:0061117 |
negative regulation of cardiac muscle tissue growth(GO:0055022) negative regulation of cardiac muscle tissue development(GO:0055026) negative regulation of cardiac muscle cell proliferation(GO:0060044) negative regulation of heart growth(GO:0061117) |
| 0.7 |
2.0 |
GO:0046210 |
nitric oxide catabolic process(GO:0046210) |
| 0.7 |
3.9 |
GO:0032460 |
negative regulation of protein oligomerization(GO:0032460) negative regulation of protein homooligomerization(GO:0032463) |
| 0.6 |
1.9 |
GO:1990170 |
detoxification of cadmium ion(GO:0071585) stress response to cadmium ion(GO:1990170) |
| 0.6 |
2.5 |
GO:0071379 |
cellular response to prostaglandin stimulus(GO:0071379) |
| 0.6 |
6.2 |
GO:0031017 |
exocrine pancreas development(GO:0031017) |
| 0.6 |
3.7 |
GO:0045654 |
positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.6 |
3.7 |
GO:1904729 |
regulation of intestinal cholesterol absorption(GO:0030300) regulation of intestinal absorption(GO:1904478) regulation of intestinal lipid absorption(GO:1904729) |
| 0.6 |
1.2 |
GO:0014874 |
response to stimulus involved in regulation of muscle adaptation(GO:0014874) |
| 0.6 |
1.7 |
GO:0043095 |
regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.5 |
3.2 |
GO:0010832 |
negative regulation of myotube differentiation(GO:0010832) |
| 0.5 |
4.2 |
GO:0006561 |
proline biosynthetic process(GO:0006561) |
| 0.5 |
1.6 |
GO:0003011 |
diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
| 0.5 |
1.5 |
GO:0070407 |
oxidation-dependent protein catabolic process(GO:0070407) |
| 0.5 |
2.0 |
GO:0014053 |
negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 0.5 |
1.4 |
GO:0070672 |
response to interleukin-15(GO:0070672) |
| 0.4 |
1.3 |
GO:1901419 |
regulation of response to alcohol(GO:1901419) |
| 0.4 |
4.0 |
GO:0070327 |
thyroid hormone transport(GO:0070327) |
| 0.4 |
1.3 |
GO:0035461 |
vitamin transmembrane transport(GO:0035461) |
| 0.4 |
1.2 |
GO:0031077 |
post-embryonic camera-type eye development(GO:0031077) |
| 0.4 |
2.8 |
GO:0030174 |
regulation of DNA-dependent DNA replication initiation(GO:0030174) |
| 0.4 |
2.3 |
GO:0045945 |
positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
| 0.4 |
1.1 |
GO:0032328 |
alanine transport(GO:0032328) |
| 0.4 |
0.4 |
GO:2000644 |
low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) regulation of receptor catabolic process(GO:2000644) |
| 0.4 |
0.7 |
GO:0035405 |
histone-threonine phosphorylation(GO:0035405) |
| 0.4 |
1.1 |
GO:0021919 |
BMP signaling pathway involved in spinal cord dorsal/ventral patterning(GO:0021919) |
| 0.4 |
1.1 |
GO:0046208 |
spermine catabolic process(GO:0046208) |
| 0.3 |
1.0 |
GO:0090206 |
negative regulation of cholesterol biosynthetic process(GO:0045541) negative regulation of cholesterol metabolic process(GO:0090206) |
| 0.3 |
1.0 |
GO:0010586 |
miRNA metabolic process(GO:0010586) miRNA catabolic process(GO:0010587) |
| 0.3 |
0.3 |
GO:0045579 |
regulation of B cell differentiation(GO:0045577) positive regulation of B cell differentiation(GO:0045579) |
| 0.3 |
1.0 |
GO:0001830 |
trophectodermal cell fate commitment(GO:0001830) |
| 0.3 |
0.3 |
GO:0060157 |
urinary bladder development(GO:0060157) |
| 0.3 |
1.0 |
GO:0000738 |
DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.3 |
0.3 |
GO:0060677 |
ureteric bud elongation(GO:0060677) |
| 0.3 |
1.0 |
GO:0032927 |
positive regulation of activin receptor signaling pathway(GO:0032927) |
| 0.3 |
1.0 |
GO:0071883 |
adrenergic receptor signaling pathway(GO:0071875) activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
| 0.3 |
0.9 |
GO:0015920 |
lipopolysaccharide transport(GO:0015920) |
| 0.3 |
1.6 |
GO:0060397 |
JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.3 |
0.9 |
GO:0071848 |
regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) TNFSF11-mediated signaling pathway(GO:0071847) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.3 |
1.2 |
GO:0045199 |
maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.3 |
0.6 |
GO:0021675 |
nerve development(GO:0021675) |
| 0.3 |
1.2 |
GO:0051573 |
negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.3 |
0.9 |
GO:0006884 |
cell volume homeostasis(GO:0006884) |
| 0.3 |
0.9 |
GO:0019827 |
stem cell population maintenance(GO:0019827) |
| 0.3 |
1.2 |
GO:0051712 |
positive regulation of killing of cells of other organism(GO:0051712) |
| 0.3 |
0.9 |
GO:0021837 |
motogenic signaling involved in postnatal olfactory bulb interneuron migration(GO:0021837) regulation of mesodermal cell fate specification(GO:0042661) lateral mesodermal cell fate commitment(GO:0048372) lateral mesodermal cell fate specification(GO:0048377) regulation of lateral mesodermal cell fate specification(GO:0048378) regulation of mesoderm development(GO:2000380) |
| 0.3 |
0.6 |
GO:0032898 |
neurotrophin production(GO:0032898) |
| 0.3 |
0.8 |
GO:0034139 |
regulation of toll-like receptor 3 signaling pathway(GO:0034139) |
| 0.3 |
1.1 |
GO:0006542 |
glutamine biosynthetic process(GO:0006542) |
| 0.3 |
0.3 |
GO:0071312 |
cellular response to alkaloid(GO:0071312) |
| 0.3 |
0.3 |
GO:0046520 |
diol biosynthetic process(GO:0034312) sphingosine biosynthetic process(GO:0046512) sphingoid biosynthetic process(GO:0046520) |
| 0.3 |
0.3 |
GO:0042362 |
fat-soluble vitamin biosynthetic process(GO:0042362) |
| 0.3 |
0.3 |
GO:0042100 |
B cell proliferation(GO:0042100) |
| 0.3 |
0.8 |
GO:0009405 |
pathogenesis(GO:0009405) |
| 0.3 |
0.8 |
GO:0070734 |
histone H3-K27 methylation(GO:0070734) |
| 0.3 |
5.3 |
GO:0014037 |
Schwann cell differentiation(GO:0014037) |
| 0.3 |
0.8 |
GO:0019886 |
antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
| 0.3 |
1.3 |
GO:0009439 |
cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
| 0.3 |
0.8 |
GO:0071280 |
cellular response to copper ion(GO:0071280) |
| 0.3 |
1.5 |
GO:0060684 |
epithelial-mesenchymal cell signaling(GO:0060684) |
| 0.3 |
0.3 |
GO:0071371 |
cellular response to gonadotropin stimulus(GO:0071371) cellular response to follicle-stimulating hormone stimulus(GO:0071372) |
| 0.3 |
2.6 |
GO:0022027 |
interkinetic nuclear migration(GO:0022027) |
| 0.3 |
0.3 |
GO:0030301 |
sterol transport(GO:0015918) cholesterol transport(GO:0030301) |
| 0.3 |
1.0 |
GO:0006682 |
galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
| 0.3 |
1.0 |
GO:0033622 |
integrin activation(GO:0033622) regulation of integrin activation(GO:0033623) positive regulation of integrin activation(GO:0033625) |
| 0.2 |
0.7 |
GO:0032571 |
response to vitamin K(GO:0032571) |
| 0.2 |
1.0 |
GO:0042118 |
endothelial cell activation(GO:0042118) |
| 0.2 |
1.7 |
GO:0040032 |
post-embryonic body morphogenesis(GO:0040032) |
| 0.2 |
0.7 |
GO:0045719 |
negative regulation of glycogen biosynthetic process(GO:0045719) |
| 0.2 |
0.7 |
GO:0046015 |
carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
| 0.2 |
0.5 |
GO:0042542 |
response to hydrogen peroxide(GO:0042542) |
| 0.2 |
0.9 |
GO:0006562 |
proline catabolic process(GO:0006562) |
| 0.2 |
0.9 |
GO:0072284 |
visceral serous pericardium development(GO:0061032) S-shaped body morphogenesis(GO:0072050) metanephric S-shaped body morphogenesis(GO:0072284) |
| 0.2 |
1.4 |
GO:0090080 |
positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.2 |
0.7 |
GO:1901142 |
insulin processing(GO:0030070) insulin metabolic process(GO:1901142) |
| 0.2 |
0.7 |
GO:0034442 |
plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
| 0.2 |
0.2 |
GO:0035162 |
embryonic hemopoiesis(GO:0035162) |
| 0.2 |
0.4 |
GO:0000414 |
regulation of histone H3-K36 methylation(GO:0000414) |
| 0.2 |
1.1 |
GO:0046607 |
positive regulation of centrosome cycle(GO:0046607) |
| 0.2 |
0.9 |
GO:0070935 |
3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.2 |
0.4 |
GO:0032329 |
serine transport(GO:0032329) |
| 0.2 |
0.4 |
GO:0060666 |
dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
| 0.2 |
0.9 |
GO:0060272 |
embryonic skeletal joint morphogenesis(GO:0060272) embryonic skeletal joint development(GO:0072498) |
| 0.2 |
2.1 |
GO:1901985 |
positive regulation of histone acetylation(GO:0035066) positive regulation of protein acetylation(GO:1901985) positive regulation of peptidyl-lysine acetylation(GO:2000758) |
| 0.2 |
1.9 |
GO:0043951 |
negative regulation of cAMP-mediated signaling(GO:0043951) |
| 0.2 |
0.2 |
GO:0007584 |
response to nutrient(GO:0007584) |
| 0.2 |
0.4 |
GO:0014887 |
muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.2 |
1.1 |
GO:0032780 |
negative regulation of ATPase activity(GO:0032780) |
| 0.2 |
1.9 |
GO:0070189 |
kynurenine metabolic process(GO:0070189) |
| 0.2 |
0.4 |
GO:0002455 |
humoral immune response mediated by circulating immunoglobulin(GO:0002455) |
| 0.2 |
1.3 |
GO:0000089 |
mitotic metaphase(GO:0000089) |
| 0.2 |
0.8 |
GO:0071218 |
cellular response to misfolded protein(GO:0071218) |
| 0.2 |
0.6 |
GO:0072217 |
negative regulation of metanephros development(GO:0072217) |
| 0.2 |
1.0 |
GO:0003070 |
age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) |
| 0.2 |
0.2 |
GO:0045082 |
positive regulation of interleukin-10 biosynthetic process(GO:0045082) |
| 0.2 |
0.8 |
GO:0001969 |
activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) positive regulation of activation of membrane attack complex(GO:0001970) positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
| 0.2 |
0.6 |
GO:0031648 |
protein destabilization(GO:0031648) |
| 0.2 |
0.8 |
GO:0006391 |
transcription initiation from mitochondrial promoter(GO:0006391) |
| 0.2 |
0.4 |
GO:0001938 |
positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.2 |
0.8 |
GO:0010157 |
response to chlorate(GO:0010157) |
| 0.2 |
1.0 |
GO:0006975 |
DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 |
0.6 |
GO:0060687 |
regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
| 0.2 |
0.4 |
GO:0032410 |
negative regulation of transporter activity(GO:0032410) |
| 0.2 |
0.6 |
GO:0005997 |
xylulose metabolic process(GO:0005997) |
| 0.2 |
0.2 |
GO:0072124 |
glomerular mesangial cell proliferation(GO:0072110) regulation of glomerular mesangial cell proliferation(GO:0072124) regulation of glomerulus development(GO:0090192) |
| 0.2 |
1.0 |
GO:0031665 |
negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.2 |
1.0 |
GO:0030952 |
establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) establishment or maintenance of cytoskeleton polarity(GO:0030952) |
| 0.2 |
0.6 |
GO:0006782 |
protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.2 |
0.4 |
GO:0051481 |
negative regulation of cytosolic calcium ion concentration(GO:0051481) |
| 0.2 |
0.2 |
GO:0043534 |
blood vessel endothelial cell migration(GO:0043534) |
| 0.2 |
1.9 |
GO:0006600 |
creatine metabolic process(GO:0006600) |
| 0.2 |
0.6 |
GO:0032241 |
positive regulation of nucleobase-containing compound transport(GO:0032241) positive regulation of RNA export from nucleus(GO:0046833) |
| 0.2 |
2.6 |
GO:0030212 |
hyaluronan metabolic process(GO:0030212) |
| 0.2 |
1.7 |
GO:0045793 |
positive regulation of cell size(GO:0045793) |
| 0.2 |
1.5 |
GO:0042074 |
cell migration involved in gastrulation(GO:0042074) |
| 0.2 |
0.6 |
GO:0008218 |
bioluminescence(GO:0008218) |
| 0.2 |
0.7 |
GO:0015992 |
proton transport(GO:0015992) |
| 0.2 |
2.0 |
GO:0034260 |
negative regulation of GTPase activity(GO:0034260) |
| 0.2 |
0.9 |
GO:0045010 |
actin nucleation(GO:0045010) |
| 0.2 |
0.5 |
GO:0046292 |
formaldehyde metabolic process(GO:0046292) |
| 0.2 |
1.6 |
GO:0006020 |
inositol metabolic process(GO:0006020) |
| 0.2 |
0.7 |
GO:0040016 |
embryonic cleavage(GO:0040016) |
| 0.2 |
1.2 |
GO:0015671 |
oxygen transport(GO:0015671) |
| 0.2 |
3.3 |
GO:0009086 |
methionine biosynthetic process(GO:0009086) |
| 0.2 |
0.5 |
GO:0043366 |
beta selection(GO:0043366) |
| 0.2 |
0.9 |
GO:0045956 |
positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
| 0.2 |
0.5 |
GO:0060370 |
susceptibility to T cell mediated cytotoxicity(GO:0060370) |
| 0.2 |
0.7 |
GO:0071894 |
histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.2 |
0.3 |
GO:0006670 |
sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
| 0.2 |
0.5 |
GO:0043371 |
negative regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043371) negative regulation of T-helper cell differentiation(GO:0045623) negative regulation of CD4-positive, alpha-beta T cell activation(GO:2000515) |
| 0.2 |
0.7 |
GO:0002268 |
follicular dendritic cell activation(GO:0002266) follicular dendritic cell differentiation(GO:0002268) |
| 0.2 |
0.5 |
GO:0002082 |
regulation of oxidative phosphorylation(GO:0002082) |
| 0.2 |
0.2 |
GO:0006910 |
phagocytosis, recognition(GO:0006910) |
| 0.2 |
0.5 |
GO:0060080 |
inhibitory postsynaptic potential(GO:0060080) |
| 0.2 |
1.5 |
GO:0006546 |
glycine catabolic process(GO:0006546) |
| 0.2 |
0.5 |
GO:0006097 |
glyoxylate cycle(GO:0006097) |
| 0.2 |
0.2 |
GO:0002385 |
innate immune response in mucosa(GO:0002227) mucosal immune response(GO:0002385) |
| 0.2 |
0.7 |
GO:0060976 |
coronary vasculature development(GO:0060976) |
| 0.2 |
0.7 |
GO:0060694 |
regulation of cholesterol transporter activity(GO:0060694) |
| 0.2 |
2.0 |
GO:0034643 |
establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 |
0.8 |
GO:0032878 |
regulation of establishment or maintenance of cell polarity(GO:0032878) |
| 0.2 |
0.3 |
GO:0003148 |
outflow tract septum morphogenesis(GO:0003148) |
| 0.2 |
0.2 |
GO:0010165 |
response to X-ray(GO:0010165) |
| 0.2 |
0.2 |
GO:0060340 |
positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
| 0.2 |
0.6 |
GO:0031580 |
membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
| 0.2 |
0.8 |
GO:0014067 |
negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
| 0.2 |
1.4 |
GO:0035590 |
purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.2 |
0.8 |
GO:0006783 |
heme biosynthetic process(GO:0006783) heme metabolic process(GO:0042168) pigment biosynthetic process(GO:0046148) |
| 0.2 |
0.5 |
GO:0003289 |
septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
| 0.2 |
0.3 |
GO:0060457 |
negative regulation of digestive system process(GO:0060457) |
| 0.2 |
0.5 |
GO:0018916 |
nitrobenzene metabolic process(GO:0018916) |
| 0.2 |
1.1 |
GO:0019264 |
glycine biosynthetic process from serine(GO:0019264) |
| 0.2 |
0.3 |
GO:0045750 |
obsolete positive regulation of S phase of mitotic cell cycle(GO:0045750) |
| 0.2 |
0.6 |
GO:0051534 |
negative regulation of NFAT protein import into nucleus(GO:0051534) |
| 0.1 |
0.1 |
GO:0014063 |
regulation of serotonin secretion(GO:0014062) negative regulation of serotonin secretion(GO:0014063) |
| 0.1 |
1.5 |
GO:0009113 |
purine nucleobase biosynthetic process(GO:0009113) |
| 0.1 |
1.0 |
GO:0051383 |
kinetochore assembly(GO:0051382) kinetochore organization(GO:0051383) |
| 0.1 |
0.3 |
GO:0033135 |
regulation of peptidyl-serine phosphorylation(GO:0033135) |
| 0.1 |
0.4 |
GO:0019242 |
methylglyoxal biosynthetic process(GO:0019242) |
| 0.1 |
0.6 |
GO:0032736 |
positive regulation of interleukin-13 production(GO:0032736) |
| 0.1 |
0.1 |
GO:0035090 |
maintenance of apical/basal cell polarity(GO:0035090) |
| 0.1 |
0.6 |
GO:0048642 |
negative regulation of skeletal muscle tissue development(GO:0048642) |
| 0.1 |
0.6 |
GO:0002313 |
mature B cell differentiation involved in immune response(GO:0002313) |
| 0.1 |
0.3 |
GO:0071699 |
olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
| 0.1 |
0.6 |
GO:0015868 |
purine ribonucleotide transport(GO:0015868) |
| 0.1 |
6.8 |
GO:0006958 |
complement activation, classical pathway(GO:0006958) |
| 0.1 |
0.1 |
GO:0032754 |
positive regulation of interleukin-5 production(GO:0032754) |
| 0.1 |
0.4 |
GO:0032071 |
regulation of endodeoxyribonuclease activity(GO:0032071) |
| 0.1 |
0.6 |
GO:0002032 |
desensitization of G-protein coupled receptor protein signaling pathway by arrestin(GO:0002032) |
| 0.1 |
0.4 |
GO:0006188 |
IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
| 0.1 |
0.8 |
GO:0019673 |
GDP-mannose metabolic process(GO:0019673) |
| 0.1 |
0.4 |
GO:0032119 |
sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
| 0.1 |
1.0 |
GO:0006896 |
Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
| 0.1 |
1.4 |
GO:0015937 |
coenzyme A biosynthetic process(GO:0015937) |
| 0.1 |
0.5 |
GO:0010716 |
regulation of extracellular matrix disassembly(GO:0010715) negative regulation of extracellular matrix disassembly(GO:0010716) regulation of extracellular matrix organization(GO:1903053) negative regulation of extracellular matrix organization(GO:1903054) |
| 0.1 |
0.1 |
GO:0051770 |
positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
| 0.1 |
0.3 |
GO:0031297 |
replication fork processing(GO:0031297) |
| 0.1 |
0.8 |
GO:0010842 |
retina layer formation(GO:0010842) |
| 0.1 |
0.4 |
GO:0034626 |
fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
| 0.1 |
0.3 |
GO:0051438 |
regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.1 |
0.8 |
GO:0030186 |
melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
| 0.1 |
0.4 |
GO:0018095 |
protein polyglutamylation(GO:0018095) |
| 0.1 |
0.5 |
GO:0060025 |
regulation of synaptic activity(GO:0060025) |
| 0.1 |
0.3 |
GO:0001543 |
ovarian follicle rupture(GO:0001543) |
| 0.1 |
0.1 |
GO:0030511 |
positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
| 0.1 |
0.3 |
GO:0019318 |
hexose metabolic process(GO:0019318) |
| 0.1 |
0.9 |
GO:0003091 |
renal water homeostasis(GO:0003091) |
| 0.1 |
0.1 |
GO:0070874 |
negative regulation of glycogen metabolic process(GO:0070874) |
| 0.1 |
0.9 |
GO:0001782 |
B cell homeostasis(GO:0001782) |
| 0.1 |
0.9 |
GO:0042797 |
5S class rRNA transcription from RNA polymerase III type 1 promoter(GO:0042791) tRNA transcription from RNA polymerase III promoter(GO:0042797) |
| 0.1 |
0.7 |
GO:0043316 |
natural killer cell activation involved in immune response(GO:0002323) cytotoxic T cell degranulation(GO:0043316) natural killer cell degranulation(GO:0043320) |
| 0.1 |
0.6 |
GO:0006686 |
sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 |
0.6 |
GO:0046642 |
negative regulation of alpha-beta T cell proliferation(GO:0046642) |
| 0.1 |
0.2 |
GO:0045599 |
negative regulation of fat cell differentiation(GO:0045599) |
| 0.1 |
0.5 |
GO:0007389 |
pattern specification process(GO:0007389) |
| 0.1 |
0.5 |
GO:0045048 |
protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 0.1 |
0.5 |
GO:0042866 |
pyruvate biosynthetic process(GO:0042866) |
| 0.1 |
1.3 |
GO:0060736 |
prostate gland growth(GO:0060736) |
| 0.1 |
0.9 |
GO:0002326 |
B cell lineage commitment(GO:0002326) |
| 0.1 |
0.9 |
GO:0070779 |
D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
| 0.1 |
0.5 |
GO:0045218 |
zonula adherens maintenance(GO:0045218) |
| 0.1 |
0.5 |
GO:0032495 |
response to muramyl dipeptide(GO:0032495) |
| 0.1 |
1.9 |
GO:0006750 |
glutathione biosynthetic process(GO:0006750) |
| 0.1 |
0.7 |
GO:0015886 |
heme transport(GO:0015886) |
| 0.1 |
0.5 |
GO:0009048 |
dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.1 |
1.0 |
GO:0006069 |
ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
| 0.1 |
1.1 |
GO:0018126 |
protein hydroxylation(GO:0018126) |
| 0.1 |
0.7 |
GO:0008089 |
anterograde axonal transport(GO:0008089) |
| 0.1 |
0.9 |
GO:0002920 |
regulation of humoral immune response(GO:0002920) |
| 0.1 |
0.6 |
GO:0045292 |
mRNA cis splicing, via spliceosome(GO:0045292) |
| 0.1 |
1.2 |
GO:0006002 |
fructose 6-phosphate metabolic process(GO:0006002) |
| 0.1 |
1.8 |
GO:0000303 |
response to superoxide(GO:0000303) |
| 0.1 |
1.3 |
GO:0051318 |
G1 phase(GO:0051318) |
| 0.1 |
0.1 |
GO:0071364 |
cellular response to epidermal growth factor stimulus(GO:0071364) |
| 0.1 |
1.0 |
GO:0055003 |
cardiac myofibril assembly(GO:0055003) |
| 0.1 |
0.6 |
GO:0060046 |
regulation of acrosome reaction(GO:0060046) |
| 0.1 |
0.5 |
GO:0009103 |
lipopolysaccharide biosynthetic process(GO:0009103) |
| 0.1 |
0.7 |
GO:0006611 |
protein export from nucleus(GO:0006611) |
| 0.1 |
3.3 |
GO:0030593 |
neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
| 0.1 |
1.2 |
GO:0015074 |
DNA integration(GO:0015074) |
| 0.1 |
0.1 |
GO:0014052 |
regulation of gamma-aminobutyric acid secretion(GO:0014052) |
| 0.1 |
0.3 |
GO:0007206 |
phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.1 |
0.1 |
GO:0051445 |
regulation of meiotic cell cycle(GO:0051445) |
| 0.1 |
0.2 |
GO:0032713 |
negative regulation of interleukin-4 production(GO:0032713) |
| 0.1 |
0.7 |
GO:0009450 |
gamma-aminobutyric acid metabolic process(GO:0009448) gamma-aminobutyric acid catabolic process(GO:0009450) |
| 0.1 |
0.3 |
GO:0016266 |
O-glycan processing(GO:0016266) |
| 0.1 |
0.3 |
GO:0051066 |
dihydrobiopterin metabolic process(GO:0051066) |
| 0.1 |
0.3 |
GO:0007221 |
positive regulation of transcription of Notch receptor target(GO:0007221) |
| 0.1 |
0.1 |
GO:0006072 |
glycerol-3-phosphate metabolic process(GO:0006072) |
| 0.1 |
1.7 |
GO:0006541 |
glutamine metabolic process(GO:0006541) |
| 0.1 |
0.6 |
GO:0046831 |
regulation of RNA export from nucleus(GO:0046831) |
| 0.1 |
0.4 |
GO:0046778 |
modification by virus of host mRNA processing(GO:0046778) |
| 0.1 |
0.8 |
GO:0034392 |
negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
| 0.1 |
0.3 |
GO:0048670 |
regulation of collateral sprouting(GO:0048670) |
| 0.1 |
0.8 |
GO:0043569 |
negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
| 0.1 |
3.8 |
GO:0008654 |
phospholipid biosynthetic process(GO:0008654) |
| 0.1 |
0.3 |
GO:0045198 |
establishment of epithelial cell apical/basal polarity(GO:0045198) |
| 0.1 |
0.1 |
GO:0085020 |
protein K27-linked ubiquitination(GO:0044314) protein K6-linked ubiquitination(GO:0085020) |
| 0.1 |
0.9 |
GO:0007130 |
synaptonemal complex assembly(GO:0007130) |
| 0.1 |
0.5 |
GO:0046855 |
phosphorylated carbohydrate dephosphorylation(GO:0046838) inositol phosphate dephosphorylation(GO:0046855) |
| 0.1 |
1.1 |
GO:0009404 |
toxin metabolic process(GO:0009404) |
| 0.1 |
0.3 |
GO:0032223 |
negative regulation of synaptic transmission, cholinergic(GO:0032223) neurotransmitter receptor biosynthetic process(GO:0045212) |
| 0.1 |
0.2 |
GO:0051972 |
regulation of telomerase activity(GO:0051972) negative regulation of telomerase activity(GO:0051974) |
| 0.1 |
0.3 |
GO:0052805 |
histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
| 0.1 |
0.3 |
GO:0044321 |
cellular response to leptin stimulus(GO:0044320) response to leptin(GO:0044321) |
| 0.1 |
0.1 |
GO:0010216 |
maintenance of DNA methylation(GO:0010216) |
| 0.1 |
2.7 |
GO:0031572 |
G2 DNA damage checkpoint(GO:0031572) |
| 0.1 |
0.2 |
GO:0045875 |
negative regulation of sister chromatid cohesion(GO:0045875) |
| 0.1 |
8.1 |
GO:0051781 |
positive regulation of cell division(GO:0051781) |
| 0.1 |
0.7 |
GO:0006610 |
ribosomal protein import into nucleus(GO:0006610) |
| 0.1 |
0.3 |
GO:0001544 |
initiation of primordial ovarian follicle growth(GO:0001544) |
| 0.1 |
0.3 |
GO:0010761 |
fibroblast migration(GO:0010761) |
| 0.1 |
1.0 |
GO:0046051 |
GTP biosynthetic process(GO:0006183) UTP biosynthetic process(GO:0006228) CTP biosynthetic process(GO:0006241) pyrimidine ribonucleoside triphosphate metabolic process(GO:0009208) pyrimidine ribonucleoside triphosphate biosynthetic process(GO:0009209) CTP metabolic process(GO:0046036) UTP metabolic process(GO:0046051) |
| 0.1 |
0.8 |
GO:0071353 |
cellular response to interleukin-4(GO:0071353) |
| 0.1 |
0.1 |
GO:0007091 |
metaphase/anaphase transition of mitotic cell cycle(GO:0007091) regulation of mitotic sister chromatid separation(GO:0010965) regulation of mitotic sister chromatid segregation(GO:0033047) metaphase/anaphase transition of cell cycle(GO:0044784) chromosome separation(GO:0051304) mitotic sister chromatid separation(GO:0051306) |
| 0.1 |
0.4 |
GO:0071674 |
mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.1 |
0.2 |
GO:0010834 |
obsolete telomere maintenance via telomere shortening(GO:0010834) |
| 0.1 |
0.8 |
GO:0032869 |
cellular response to insulin stimulus(GO:0032869) |
| 0.1 |
0.5 |
GO:0045722 |
positive regulation of gluconeogenesis(GO:0045722) |
| 0.1 |
0.3 |
GO:0018283 |
metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.1 |
0.9 |
GO:0043570 |
maintenance of DNA repeat elements(GO:0043570) |
| 0.1 |
0.4 |
GO:0006216 |
cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
| 0.1 |
0.4 |
GO:0035520 |
monoubiquitinated protein deubiquitination(GO:0035520) |
| 0.1 |
0.5 |
GO:0050957 |
equilibrioception(GO:0050957) |
| 0.1 |
0.9 |
GO:0048387 |
negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.1 |
1.0 |
GO:0072073 |
kidney epithelium development(GO:0072073) |
| 0.1 |
0.3 |
GO:0070245 |
positive regulation of lymphocyte apoptotic process(GO:0070230) positive regulation of T cell apoptotic process(GO:0070234) positive regulation of thymocyte apoptotic process(GO:0070245) |
| 0.1 |
0.3 |
GO:0032092 |
positive regulation of protein binding(GO:0032092) |
| 0.1 |
0.2 |
GO:0030997 |
centriole-centriole cohesion(GO:0010457) regulation of centriole-centriole cohesion(GO:0030997) |
| 0.1 |
2.7 |
GO:0030866 |
cortical actin cytoskeleton organization(GO:0030866) |
| 0.1 |
0.5 |
GO:0045075 |
interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
| 0.1 |
3.4 |
GO:0060041 |
retina development in camera-type eye(GO:0060041) |
| 0.1 |
0.4 |
GO:0048934 |
peripheral nervous system neuron differentiation(GO:0048934) peripheral nervous system neuron development(GO:0048935) |
| 0.1 |
0.1 |
GO:0032388 |
positive regulation of intracellular transport(GO:0032388) |
| 0.1 |
1.7 |
GO:0014066 |
regulation of phosphatidylinositol 3-kinase signaling(GO:0014066) |
| 0.1 |
0.3 |
GO:0006273 |
lagging strand elongation(GO:0006273) |
| 0.1 |
0.8 |
GO:0034755 |
iron ion transmembrane transport(GO:0034755) |
| 0.1 |
0.9 |
GO:0045600 |
positive regulation of fat cell differentiation(GO:0045600) |
| 0.1 |
0.4 |
GO:0000491 |
small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.1 |
0.3 |
GO:0007028 |
cytoplasm organization(GO:0007028) |
| 0.1 |
1.9 |
GO:0050766 |
positive regulation of phagocytosis(GO:0050766) |
| 0.1 |
0.6 |
GO:0016561 |
protein import into peroxisome matrix, translocation(GO:0016561) |
| 0.1 |
0.7 |
GO:0032148 |
activation of protein kinase B activity(GO:0032148) |
| 0.1 |
1.5 |
GO:0016578 |
histone deubiquitination(GO:0016578) |
| 0.1 |
0.1 |
GO:0000305 |
response to oxygen radical(GO:0000305) |
| 0.1 |
0.3 |
GO:0050884 |
neuromuscular process controlling posture(GO:0050884) |
| 0.1 |
0.5 |
GO:0003279 |
cardiac septum development(GO:0003279) |
| 0.1 |
2.2 |
GO:0034035 |
purine ribonucleoside bisphosphate metabolic process(GO:0034035) 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
| 0.1 |
1.2 |
GO:0006978 |
DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
| 0.1 |
0.4 |
GO:0010957 |
negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 0.1 |
0.4 |
GO:0032776 |
DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
| 0.1 |
1.0 |
GO:0007076 |
mitotic chromosome condensation(GO:0007076) |
| 0.1 |
0.2 |
GO:0008054 |
negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
| 0.1 |
0.1 |
GO:0007292 |
female gamete generation(GO:0007292) |
| 0.1 |
0.5 |
GO:0031274 |
pseudopodium assembly(GO:0031269) regulation of pseudopodium assembly(GO:0031272) positive regulation of pseudopodium assembly(GO:0031274) |
| 0.1 |
0.6 |
GO:0045988 |
negative regulation of striated muscle contraction(GO:0045988) |
| 0.1 |
0.2 |
GO:0046486 |
glycerolipid metabolic process(GO:0046486) |
| 0.1 |
0.4 |
GO:0071731 |
response to nitric oxide(GO:0071731) |
| 0.1 |
0.8 |
GO:0009249 |
protein lipoylation(GO:0009249) |
| 0.1 |
0.3 |
GO:0051958 |
methotrexate transport(GO:0051958) |
| 0.1 |
0.3 |
GO:0051607 |
defense response to virus(GO:0051607) |
| 0.1 |
0.3 |
GO:0090224 |
regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
| 0.1 |
3.7 |
GO:0043487 |
regulation of RNA stability(GO:0043487) |
| 0.1 |
0.3 |
GO:0019985 |
translesion synthesis(GO:0019985) |
| 0.1 |
0.9 |
GO:0006776 |
vitamin A metabolic process(GO:0006776) |
| 0.1 |
0.3 |
GO:0019605 |
butyrate metabolic process(GO:0019605) |
| 0.1 |
0.5 |
GO:0001779 |
natural killer cell differentiation(GO:0001779) |
| 0.1 |
0.5 |
GO:0046874 |
quinolinate metabolic process(GO:0046874) |
| 0.1 |
0.2 |
GO:0042733 |
embryonic digit morphogenesis(GO:0042733) |
| 0.1 |
1.0 |
GO:0007168 |
receptor guanylyl cyclase signaling pathway(GO:0007168) |
| 0.1 |
0.2 |
GO:0048714 |
positive regulation of oligodendrocyte differentiation(GO:0048714) |
| 0.1 |
0.7 |
GO:0033006 |
regulation of mast cell activation involved in immune response(GO:0033006) regulation of mast cell degranulation(GO:0043304) |
| 0.1 |
0.3 |
GO:0007231 |
osmosensory signaling pathway(GO:0007231) |
| 0.1 |
0.6 |
GO:0006622 |
protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
| 0.1 |
0.5 |
GO:0021800 |
cerebral cortex tangential migration(GO:0021800) |
| 0.1 |
0.1 |
GO:0002374 |
cytokine secretion involved in immune response(GO:0002374) chronic inflammatory response to antigenic stimulus(GO:0002439) regulation of cytokine secretion involved in immune response(GO:0002739) negative regulation of cytokine secretion involved in immune response(GO:0002740) regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
| 0.1 |
0.2 |
GO:0001706 |
endoderm formation(GO:0001706) |
| 0.1 |
0.9 |
GO:0030206 |
chondroitin sulfate biosynthetic process(GO:0030206) |
| 0.1 |
0.3 |
GO:0015917 |
aminophospholipid transport(GO:0015917) |
| 0.1 |
1.0 |
GO:0032615 |
interleukin-12 production(GO:0032615) |
| 0.1 |
0.3 |
GO:0048739 |
cardiac muscle fiber development(GO:0048739) |
| 0.1 |
0.2 |
GO:0000114 |
obsolete regulation of transcription involved in G1 phase of mitotic cell cycle(GO:0000114) |
| 0.1 |
0.2 |
GO:0034086 |
maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.1 |
0.6 |
GO:0046653 |
tetrahydrofolate metabolic process(GO:0046653) |
| 0.1 |
0.3 |
GO:0060707 |
trophoblast giant cell differentiation(GO:0060707) |
| 0.1 |
0.5 |
GO:0033189 |
response to vitamin A(GO:0033189) |
| 0.1 |
0.3 |
GO:0060632 |
regulation of microtubule-based movement(GO:0060632) |
| 0.1 |
1.4 |
GO:0006386 |
transcription elongation from RNA polymerase III promoter(GO:0006385) termination of RNA polymerase III transcription(GO:0006386) |
| 0.1 |
1.8 |
GO:0050853 |
B cell receptor signaling pathway(GO:0050853) |
| 0.1 |
1.4 |
GO:0032098 |
regulation of appetite(GO:0032098) |
| 0.1 |
0.2 |
GO:0046732 |
induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by virus of host immune response(GO:0075528) |
| 0.1 |
0.1 |
GO:0008300 |
isoprenoid catabolic process(GO:0008300) |
| 0.1 |
0.1 |
GO:0032203 |
telomere formation via telomerase(GO:0032203) |
| 0.1 |
0.5 |
GO:0006422 |
aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.1 |
0.1 |
GO:0042339 |
keratan sulfate metabolic process(GO:0042339) |
| 0.1 |
0.3 |
GO:0033986 |
response to methanol(GO:0033986) response to chromate(GO:0046687) |
| 0.1 |
1.4 |
GO:0001578 |
microtubule bundle formation(GO:0001578) |
| 0.1 |
1.8 |
GO:0050830 |
defense response to Gram-positive bacterium(GO:0050830) |
| 0.1 |
0.1 |
GO:0001977 |
renal system process involved in regulation of blood volume(GO:0001977) |
| 0.1 |
0.2 |
GO:0071354 |
cellular response to interleukin-6(GO:0071354) |
| 0.1 |
0.5 |
GO:0043615 |
astrocyte cell migration(GO:0043615) |
| 0.1 |
0.9 |
GO:0032876 |
regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
| 0.1 |
0.5 |
GO:0033962 |
cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 |
0.2 |
GO:0017183 |
peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.1 |
0.2 |
GO:0042369 |
vitamin catabolic process(GO:0009111) fat-soluble vitamin catabolic process(GO:0042363) vitamin D catabolic process(GO:0042369) |
| 0.1 |
0.2 |
GO:0034616 |
response to laminar fluid shear stress(GO:0034616) |
| 0.1 |
0.5 |
GO:0090005 |
negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.1 |
0.4 |
GO:0007090 |
obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
| 0.1 |
0.2 |
GO:0051026 |
chiasma assembly(GO:0051026) |
| 0.1 |
0.5 |
GO:0006287 |
base-excision repair, gap-filling(GO:0006287) |
| 0.1 |
0.2 |
GO:0048075 |
regulation of eye pigmentation(GO:0048073) positive regulation of eye pigmentation(GO:0048075) |
| 0.1 |
0.1 |
GO:0042760 |
very long-chain fatty acid catabolic process(GO:0042760) |
| 0.1 |
0.1 |
GO:0061081 |
positive regulation of macrophage cytokine production(GO:0060907) positive regulation of myeloid leukocyte cytokine production involved in immune response(GO:0061081) |
| 0.1 |
1.0 |
GO:0010517 |
regulation of phospholipase activity(GO:0010517) positive regulation of lipase activity(GO:0060193) |
| 0.1 |
0.1 |
GO:0007064 |
mitotic sister chromatid cohesion(GO:0007064) |
| 0.1 |
0.2 |
GO:0014819 |
regulation of skeletal muscle contraction(GO:0014819) |
| 0.1 |
0.1 |
GO:0051150 |
regulation of smooth muscle cell differentiation(GO:0051150) |
| 0.1 |
0.1 |
GO:0033014 |
porphyrin-containing compound metabolic process(GO:0006778) porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
| 0.1 |
0.5 |
GO:0045007 |
depurination(GO:0045007) |
| 0.1 |
0.4 |
GO:0015712 |
hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
| 0.1 |
0.2 |
GO:0050691 |
regulation of defense response to virus by host(GO:0050691) |
| 0.1 |
0.5 |
GO:0015991 |
energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 |
0.2 |
GO:1904358 |
positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
| 0.1 |
0.5 |
GO:0046618 |
drug export(GO:0046618) |
| 0.1 |
0.1 |
GO:0051299 |
centrosome separation(GO:0051299) |
| 0.1 |
0.3 |
GO:0000463 |
maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
| 0.1 |
0.6 |
GO:0003084 |
positive regulation of systemic arterial blood pressure(GO:0003084) |
| 0.1 |
0.2 |
GO:0002087 |
regulation of respiratory gaseous exchange by neurological system process(GO:0002087) regulation of respiratory system process(GO:0044065) |
| 0.1 |
0.1 |
GO:0006537 |
glutamate biosynthetic process(GO:0006537) |
| 0.1 |
0.1 |
GO:0007538 |
primary sex determination(GO:0007538) |
| 0.1 |
0.8 |
GO:0016226 |
iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.1 |
0.6 |
GO:0030277 |
epithelial structure maintenance(GO:0010669) maintenance of gastrointestinal epithelium(GO:0030277) |
| 0.1 |
0.3 |
GO:0000966 |
RNA 5'-end processing(GO:0000966) |
| 0.1 |
0.2 |
GO:0048703 |
embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.1 |
0.1 |
GO:0001832 |
blastocyst growth(GO:0001832) inner cell mass cell proliferation(GO:0001833) |
| 0.1 |
5.4 |
GO:0006094 |
gluconeogenesis(GO:0006094) |
| 0.1 |
2.0 |
GO:0003333 |
amino acid transmembrane transport(GO:0003333) |
| 0.1 |
1.6 |
GO:0006890 |
retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
| 0.1 |
0.4 |
GO:0048172 |
regulation of short-term neuronal synaptic plasticity(GO:0048172) |
| 0.1 |
0.1 |
GO:0032074 |
negative regulation of nuclease activity(GO:0032074) |
| 0.1 |
0.3 |
GO:0033147 |
negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.1 |
0.1 |
GO:0032242 |
regulation of nucleoside transport(GO:0032242) |
| 0.1 |
0.1 |
GO:0006922 |
obsolete cleavage of lamin involved in execution phase of apoptosis(GO:0006922) |
| 0.1 |
0.6 |
GO:0016998 |
cell wall macromolecule catabolic process(GO:0016998) |
| 0.1 |
0.2 |
GO:0097237 |
cellular response to antibiotic(GO:0071236) cellular response to toxic substance(GO:0097237) |
| 0.1 |
0.2 |
GO:0008298 |
intracellular mRNA localization(GO:0008298) |
| 0.1 |
0.5 |
GO:0060391 |
positive regulation of SMAD protein import into nucleus(GO:0060391) |
| 0.1 |
0.1 |
GO:0048332 |
mesoderm morphogenesis(GO:0048332) |
| 0.1 |
0.5 |
GO:0015858 |
nucleoside transport(GO:0015858) |
| 0.1 |
1.4 |
GO:0007194 |
negative regulation of adenylate cyclase activity(GO:0007194) negative regulation of cyclase activity(GO:0031280) negative regulation of lyase activity(GO:0051350) |
| 0.1 |
0.5 |
GO:0016075 |
rRNA catabolic process(GO:0016075) |
| 0.1 |
0.3 |
GO:0051895 |
negative regulation of focal adhesion assembly(GO:0051895) negative regulation of cell junction assembly(GO:1901889) negative regulation of adherens junction organization(GO:1903392) |
| 0.1 |
0.5 |
GO:0021915 |
neural tube development(GO:0021915) |
| 0.1 |
1.1 |
GO:0009214 |
cyclic nucleotide catabolic process(GO:0009214) |
| 0.1 |
0.3 |
GO:0060017 |
parathyroid gland development(GO:0060017) |
| 0.1 |
0.2 |
GO:0034145 |
positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
| 0.1 |
0.5 |
GO:0050847 |
progesterone receptor signaling pathway(GO:0050847) |
| 0.1 |
0.7 |
GO:0051568 |
histone H3-K4 methylation(GO:0051568) |
| 0.1 |
0.2 |
GO:0043046 |
DNA methylation involved in gamete generation(GO:0043046) |
| 0.1 |
0.2 |
GO:0032959 |
inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.1 |
0.9 |
GO:0006491 |
N-glycan processing(GO:0006491) |
| 0.1 |
0.4 |
GO:0006772 |
thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
| 0.1 |
0.1 |
GO:0001955 |
blood vessel maturation(GO:0001955) |
| 0.1 |
0.5 |
GO:0006027 |
glycosaminoglycan catabolic process(GO:0006027) |
| 0.1 |
0.3 |
GO:0009068 |
aspartate family amino acid catabolic process(GO:0009068) |
| 0.1 |
0.2 |
GO:0050684 |
regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
| 0.1 |
0.1 |
GO:2001259 |
positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
| 0.1 |
0.7 |
GO:0045648 |
positive regulation of erythrocyte differentiation(GO:0045648) |
| 0.1 |
0.1 |
GO:0045077 |
negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
| 0.1 |
1.1 |
GO:0034199 |
activation of protein kinase A activity(GO:0034199) |
| 0.1 |
0.9 |
GO:0030851 |
granulocyte differentiation(GO:0030851) |
| 0.1 |
0.4 |
GO:0007256 |
activation of JNKK activity(GO:0007256) |
| 0.1 |
0.7 |
GO:0007035 |
vacuolar acidification(GO:0007035) |
| 0.1 |
0.2 |
GO:0006384 |
transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.1 |
0.2 |
GO:0010875 |
positive regulation of cholesterol efflux(GO:0010875) |
| 0.1 |
0.9 |
GO:0019400 |
alditol metabolic process(GO:0019400) |
| 0.1 |
0.6 |
GO:0000052 |
citrulline metabolic process(GO:0000052) |
| 0.1 |
0.3 |
GO:0042535 |
positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
| 0.1 |
0.2 |
GO:0006857 |
oligopeptide transport(GO:0006857) |
| 0.1 |
0.8 |
GO:0035036 |
binding of sperm to zona pellucida(GO:0007339) sperm-egg recognition(GO:0035036) |
| 0.1 |
4.4 |
GO:0006338 |
chromatin remodeling(GO:0006338) |
| 0.1 |
0.3 |
GO:0010745 |
negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 |
0.6 |
GO:0051319 |
mitotic G2 phase(GO:0000085) G2 phase(GO:0051319) |
| 0.1 |
0.1 |
GO:0031935 |
regulation of chromatin silencing(GO:0031935) |
| 0.1 |
0.1 |
GO:0010826 |
negative regulation of centrosome duplication(GO:0010826) negative regulation of centrosome cycle(GO:0046606) |
| 0.1 |
0.7 |
GO:0071445 |
obsolete cellular response to protein stimulus(GO:0071445) |
| 0.1 |
0.2 |
GO:0071391 |
cellular response to estrogen stimulus(GO:0071391) |
| 0.1 |
0.1 |
GO:0006398 |
mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.1 |
0.2 |
GO:0001552 |
ovarian follicle atresia(GO:0001552) |
| 0.1 |
0.3 |
GO:0046548 |
retinal rod cell development(GO:0046548) |
| 0.1 |
0.2 |
GO:0009186 |
deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
| 0.1 |
1.0 |
GO:0002687 |
positive regulation of leukocyte migration(GO:0002687) |
| 0.1 |
0.2 |
GO:0001757 |
somite specification(GO:0001757) |
| 0.1 |
0.3 |
GO:0015705 |
iodide transport(GO:0015705) |
| 0.1 |
0.6 |
GO:0006112 |
energy reserve metabolic process(GO:0006112) |
| 0.1 |
0.3 |
GO:0051918 |
negative regulation of fibrinolysis(GO:0051918) |
| 0.1 |
0.1 |
GO:0006547 |
histidine metabolic process(GO:0006547) |
| 0.1 |
0.2 |
GO:0042417 |
dopamine metabolic process(GO:0042417) |
| 0.1 |
0.3 |
GO:0006999 |
nuclear pore organization(GO:0006999) |
| 0.1 |
0.4 |
GO:0007379 |
segment specification(GO:0007379) |
| 0.1 |
0.6 |
GO:0071456 |
cellular response to decreased oxygen levels(GO:0036294) cellular response to oxygen levels(GO:0071453) cellular response to hypoxia(GO:0071456) |
| 0.1 |
1.8 |
GO:0007588 |
excretion(GO:0007588) |
| 0.1 |
0.3 |
GO:0030422 |
production of siRNA involved in RNA interference(GO:0030422) |
| 0.1 |
0.2 |
GO:0052510 |
modulation by symbiont of host defense response(GO:0052031) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) |
| 0.1 |
0.5 |
GO:1901992 |
positive regulation of cell cycle phase transition(GO:1901989) positive regulation of mitotic cell cycle phase transition(GO:1901992) |
| 0.1 |
0.2 |
GO:0015959 |
diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.1 |
0.1 |
GO:0031670 |
cellular response to nutrient(GO:0031670) |
| 0.1 |
0.1 |
GO:0051602 |
response to electrical stimulus(GO:0051602) |
| 0.1 |
0.2 |
GO:0043029 |
T cell homeostasis(GO:0043029) |
| 0.1 |
1.1 |
GO:0042274 |
ribosomal small subunit biogenesis(GO:0042274) |
| 0.1 |
0.1 |
GO:0006269 |
DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.1 |
0.4 |
GO:0051597 |
response to methylmercury(GO:0051597) |
| 0.1 |
0.1 |
GO:0002538 |
arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
| 0.1 |
0.2 |
GO:0006434 |
seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 |
0.1 |
GO:0051964 |
negative regulation of synapse assembly(GO:0051964) |
| 0.0 |
0.1 |
GO:0045953 |
negative regulation of natural killer cell mediated immunity(GO:0002716) negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
| 0.0 |
0.2 |
GO:0048388 |
endosomal lumen acidification(GO:0048388) |
| 0.0 |
0.5 |
GO:0032784 |
regulation of DNA-templated transcription, elongation(GO:0032784) |
| 0.0 |
0.2 |
GO:0032836 |
glomerular basement membrane development(GO:0032836) |
| 0.0 |
1.1 |
GO:0031647 |
regulation of protein stability(GO:0031647) |
| 0.0 |
1.0 |
GO:0002504 |
antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 0.0 |
0.0 |
GO:0044380 |
protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.0 |
0.0 |
GO:0070498 |
interleukin-1-mediated signaling pathway(GO:0070498) |
| 0.0 |
0.1 |
GO:0048537 |
mucosal-associated lymphoid tissue development(GO:0048537) |
| 0.0 |
0.0 |
GO:0007217 |
tachykinin receptor signaling pathway(GO:0007217) |
| 0.0 |
0.1 |
GO:0031167 |
rRNA methylation(GO:0031167) |
| 0.0 |
0.1 |
GO:0045668 |
negative regulation of osteoblast differentiation(GO:0045668) |
| 0.0 |
0.4 |
GO:0006516 |
glycoprotein catabolic process(GO:0006516) |
| 0.0 |
2.6 |
GO:0006959 |
humoral immune response(GO:0006959) |
| 0.0 |
0.3 |
GO:0006646 |
phosphatidylethanolamine biosynthetic process(GO:0006646) phosphatidylethanolamine metabolic process(GO:0046337) |
| 0.0 |
0.3 |
GO:0099515 |
nuclear migration along microfilament(GO:0031022) actin filament-based transport(GO:0099515) |
| 0.0 |
0.3 |
GO:0007021 |
tubulin complex assembly(GO:0007021) |
| 0.0 |
0.1 |
GO:0015693 |
magnesium ion transport(GO:0015693) |
| 0.0 |
0.4 |
GO:0048873 |
homeostasis of number of cells within a tissue(GO:0048873) |
| 0.0 |
1.6 |
GO:0006361 |
transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.0 |
0.6 |
GO:0007020 |
microtubule nucleation(GO:0007020) |
| 0.0 |
0.0 |
GO:0007128 |
meiotic prophase I(GO:0007128) |
| 0.0 |
0.5 |
GO:0060334 |
regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.0 |
0.1 |
GO:0032020 |
ISG15-protein conjugation(GO:0032020) |
| 0.0 |
0.1 |
GO:0032770 |
positive regulation of monooxygenase activity(GO:0032770) |
| 0.0 |
0.3 |
GO:0022601 |
menstrual cycle phase(GO:0022601) |
| 0.0 |
1.3 |
GO:0042147 |
retrograde transport, endosome to Golgi(GO:0042147) |
| 0.0 |
0.1 |
GO:0008065 |
establishment of blood-nerve barrier(GO:0008065) |
| 0.0 |
0.3 |
GO:0045730 |
respiratory burst(GO:0045730) |
| 0.0 |
0.7 |
GO:0006400 |
tRNA modification(GO:0006400) |
| 0.0 |
0.3 |
GO:0030219 |
megakaryocyte differentiation(GO:0030219) |
| 0.0 |
0.9 |
GO:0043101 |
purine-containing compound salvage(GO:0043101) |
| 0.0 |
0.1 |
GO:0006419 |
alanyl-tRNA aminoacylation(GO:0006419) |
| 0.0 |
0.1 |
GO:0045650 |
negative regulation of macrophage differentiation(GO:0045650) |
| 0.0 |
0.0 |
GO:0014002 |
astrocyte development(GO:0014002) |
| 0.0 |
0.5 |
GO:0001889 |
liver development(GO:0001889) hepaticobiliary system development(GO:0061008) |
| 0.0 |
0.2 |
GO:0032516 |
positive regulation of phosphoprotein phosphatase activity(GO:0032516) |
| 0.0 |
0.1 |
GO:0090073 |
positive regulation of protein homodimerization activity(GO:0090073) |
| 0.0 |
0.1 |
GO:0071384 |
cellular response to corticosteroid stimulus(GO:0071384) cellular response to glucocorticoid stimulus(GO:0071385) |
| 0.0 |
0.2 |
GO:0042475 |
odontogenesis of dentin-containing tooth(GO:0042475) |
| 0.0 |
0.3 |
GO:0001961 |
positive regulation of cytokine-mediated signaling pathway(GO:0001961) |
| 0.0 |
0.4 |
GO:0002566 |
somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.0 |
0.1 |
GO:0009162 |
deoxyribonucleoside monophosphate metabolic process(GO:0009162) pyrimidine deoxyribonucleoside monophosphate metabolic process(GO:0009176) dUMP metabolic process(GO:0046078) |
| 0.0 |
0.3 |
GO:0043982 |
histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) histone H4-K12 acetylation(GO:0043983) |
| 0.0 |
0.2 |
GO:0019255 |
glucose 1-phosphate metabolic process(GO:0019255) |
| 0.0 |
0.1 |
GO:0009988 |
cell-cell recognition(GO:0009988) |
| 0.0 |
0.2 |
GO:0010508 |
positive regulation of autophagy(GO:0010508) |
| 0.0 |
0.1 |
GO:0009067 |
aspartate family amino acid biosynthetic process(GO:0009067) |
| 0.0 |
0.5 |
GO:0051291 |
protein heterooligomerization(GO:0051291) |
| 0.0 |
0.2 |
GO:0048712 |
negative regulation of astrocyte differentiation(GO:0048712) |
| 0.0 |
0.2 |
GO:0060259 |
regulation of feeding behavior(GO:0060259) |
| 0.0 |
0.1 |
GO:0030259 |
lipid glycosylation(GO:0030259) |
| 0.0 |
0.1 |
GO:0030299 |
intestinal cholesterol absorption(GO:0030299) intestinal lipid absorption(GO:0098856) |
| 0.0 |
0.2 |
GO:0071436 |
sodium ion export(GO:0071436) |
| 0.0 |
0.2 |
GO:0019884 |
antigen processing and presentation of exogenous peptide antigen(GO:0002478) antigen processing and presentation of exogenous antigen(GO:0019884) |
| 0.0 |
0.2 |
GO:0030263 |
apoptotic chromosome condensation(GO:0030263) |
| 0.0 |
0.3 |
GO:0071230 |
cellular response to amino acid stimulus(GO:0071230) |
| 0.0 |
0.1 |
GO:0006333 |
chromatin assembly or disassembly(GO:0006333) |
| 0.0 |
0.2 |
GO:0030644 |
cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.0 |
0.2 |
GO:0030157 |
pancreatic juice secretion(GO:0030157) |
| 0.0 |
0.8 |
GO:0032012 |
regulation of ARF protein signal transduction(GO:0032012) |
| 0.0 |
0.0 |
GO:0033687 |
osteoblast proliferation(GO:0033687) |
| 0.0 |
0.5 |
GO:0030225 |
macrophage differentiation(GO:0030225) |
| 0.0 |
0.2 |
GO:0020027 |
hemoglobin metabolic process(GO:0020027) |
| 0.0 |
0.9 |
GO:0009260 |
ribonucleotide biosynthetic process(GO:0009260) |
| 0.0 |
0.4 |
GO:0018214 |
peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
| 0.0 |
0.2 |
GO:0007616 |
long-term memory(GO:0007616) |
| 0.0 |
0.1 |
GO:0051205 |
protein insertion into membrane(GO:0051205) |
| 0.0 |
0.6 |
GO:0010821 |
regulation of mitochondrion organization(GO:0010821) |
| 0.0 |
0.3 |
GO:0002021 |
response to dietary excess(GO:0002021) |
| 0.0 |
1.0 |
GO:0006699 |
bile acid biosynthetic process(GO:0006699) |
| 0.0 |
0.1 |
GO:0045824 |
negative regulation of innate immune response(GO:0045824) |
| 0.0 |
0.7 |
GO:0071377 |
cellular response to glucagon stimulus(GO:0071377) |
| 0.0 |
0.1 |
GO:0006598 |
polyamine catabolic process(GO:0006598) |
| 0.0 |
0.1 |
GO:0006940 |
regulation of smooth muscle contraction(GO:0006940) |
| 0.0 |
0.2 |
GO:0045070 |
positive regulation of viral genome replication(GO:0045070) |
| 0.0 |
0.1 |
GO:0006435 |
threonyl-tRNA aminoacylation(GO:0006435) |
| 0.0 |
0.1 |
GO:0046902 |
regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
| 0.0 |
0.3 |
GO:0030903 |
notochord development(GO:0030903) |
| 0.0 |
0.0 |
GO:0070244 |
negative regulation of T cell apoptotic process(GO:0070233) negative regulation of thymocyte apoptotic process(GO:0070244) |
| 0.0 |
0.3 |
GO:0006685 |
sphingomyelin catabolic process(GO:0006685) |
| 0.0 |
0.2 |
GO:0045056 |
transcytosis(GO:0045056) |
| 0.0 |
0.1 |
GO:0042753 |
positive regulation of circadian rhythm(GO:0042753) |
| 0.0 |
0.8 |
GO:0006953 |
acute-phase response(GO:0006953) |
| 0.0 |
0.1 |
GO:0016584 |
nucleosome positioning(GO:0016584) |
| 0.0 |
0.0 |
GO:0070192 |
synapsis(GO:0007129) chromosome organization involved in meiotic cell cycle(GO:0070192) |
| 0.0 |
0.1 |
GO:2000273 |
positive regulation of receptor activity(GO:2000273) |
| 0.0 |
0.4 |
GO:0016180 |
snRNA processing(GO:0016180) |
| 0.0 |
0.6 |
GO:0016601 |
Rac protein signal transduction(GO:0016601) |
| 0.0 |
0.1 |
GO:0016080 |
synaptic vesicle targeting(GO:0016080) |
| 0.0 |
0.2 |
GO:0032916 |
transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.0 |
0.5 |
GO:0051225 |
spindle assembly(GO:0051225) |
| 0.0 |
0.9 |
GO:0019915 |
lipid storage(GO:0019915) |
| 0.0 |
2.1 |
GO:0031295 |
lymphocyte costimulation(GO:0031294) T cell costimulation(GO:0031295) |
| 0.0 |
0.2 |
GO:0019835 |
cytolysis(GO:0019835) |
| 0.0 |
0.4 |
GO:0035024 |
negative regulation of Rho protein signal transduction(GO:0035024) |
| 0.0 |
0.0 |
GO:0002456 |
T cell mediated immunity(GO:0002456) |
| 0.0 |
0.1 |
GO:0006768 |
biotin metabolic process(GO:0006768) |
| 0.0 |
0.0 |
GO:0072201 |
negative regulation of mesenchymal cell proliferation(GO:0072201) |
| 0.0 |
0.1 |
GO:0001510 |
RNA methylation(GO:0001510) |
| 0.0 |
0.6 |
GO:0071577 |
zinc II ion transmembrane transport(GO:0071577) |
| 0.0 |
0.1 |
GO:0043278 |
response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
| 0.0 |
0.8 |
GO:0006672 |
ceramide metabolic process(GO:0006672) |
| 0.0 |
0.1 |
GO:0006907 |
pinocytosis(GO:0006907) |
| 0.0 |
0.2 |
GO:0007252 |
I-kappaB phosphorylation(GO:0007252) |
| 0.0 |
0.4 |
GO:0016458 |
gene silencing(GO:0016458) |
| 0.0 |
0.1 |
GO:0002667 |
lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) positive regulation of T cell anergy(GO:0002669) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) positive regulation of lymphocyte anergy(GO:0002913) |
| 0.0 |
0.1 |
GO:0048682 |
axon extension involved in regeneration(GO:0048677) sprouting of injured axon(GO:0048682) |
| 0.0 |
0.1 |
GO:1902692 |
regulation of neuroblast proliferation(GO:1902692) |
| 0.0 |
0.1 |
GO:0090036 |
regulation of protein kinase C signaling(GO:0090036) positive regulation of protein kinase C signaling(GO:0090037) |
| 0.0 |
0.0 |
GO:0051969 |
regulation of transmission of nerve impulse(GO:0051969) |
| 0.0 |
0.1 |
GO:0048268 |
clathrin coat assembly(GO:0048268) |
| 0.0 |
0.7 |
GO:0050885 |
neuromuscular process controlling balance(GO:0050885) |
| 0.0 |
0.1 |
GO:0006530 |
asparagine metabolic process(GO:0006528) asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
| 0.0 |
0.2 |
GO:0018026 |
peptidyl-lysine monomethylation(GO:0018026) |
| 0.0 |
0.2 |
GO:0033540 |
fatty acid beta-oxidation using acyl-CoA oxidase(GO:0033540) |
| 0.0 |
0.5 |
GO:0006613 |
cotranslational protein targeting to membrane(GO:0006613) |
| 0.0 |
0.2 |
GO:0046339 |
diacylglycerol metabolic process(GO:0046339) |
| 0.0 |
0.2 |
GO:0046827 |
positive regulation of protein export from nucleus(GO:0046827) |
| 0.0 |
0.1 |
GO:0034435 |
steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
| 0.0 |
0.2 |
GO:0009082 |
branched-chain amino acid biosynthetic process(GO:0009082) |
| 0.0 |
0.4 |
GO:0006004 |
fucose metabolic process(GO:0006004) |
| 0.0 |
0.1 |
GO:0043116 |
negative regulation of vascular permeability(GO:0043116) |
| 0.0 |
0.6 |
GO:0007131 |
reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
| 0.0 |
0.2 |
GO:0007340 |
acrosome reaction(GO:0007340) |
| 0.0 |
1.2 |
GO:0000184 |
nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.0 |
1.6 |
GO:0006369 |
termination of RNA polymerase II transcription(GO:0006369) |
| 0.0 |
0.2 |
GO:0060155 |
platelet dense granule organization(GO:0060155) |
| 0.0 |
0.1 |
GO:0030261 |
chromosome condensation(GO:0030261) |
| 0.0 |
0.3 |
GO:0009954 |
proximal/distal pattern formation(GO:0009954) |
| 0.0 |
0.5 |
GO:0036260 |
7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.0 |
0.2 |
GO:0015755 |
fructose transport(GO:0015755) |
| 0.0 |
1.5 |
GO:0001906 |
cell killing(GO:0001906) |
| 0.0 |
0.1 |
GO:0045123 |
cellular extravasation(GO:0045123) |
| 0.0 |
0.2 |
GO:0008295 |
spermidine metabolic process(GO:0008216) spermidine biosynthetic process(GO:0008295) |
| 0.0 |
0.4 |
GO:0030321 |
transepithelial chloride transport(GO:0030321) |
| 0.0 |
0.0 |
GO:0031033 |
myosin filament organization(GO:0031033) |
| 0.0 |
0.3 |
GO:0009713 |
catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
| 0.0 |
0.1 |
GO:1901881 |
positive regulation of protein depolymerization(GO:1901881) |
| 0.0 |
0.1 |
GO:0007207 |
phospholipase C-activating G-protein coupled acetylcholine receptor signaling pathway(GO:0007207) |
| 0.0 |
0.8 |
GO:0007214 |
gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 |
0.1 |
GO:0070633 |
transepithelial transport(GO:0070633) |
| 0.0 |
0.0 |
GO:0046826 |
negative regulation of protein export from nucleus(GO:0046826) |
| 0.0 |
0.1 |
GO:0010507 |
negative regulation of autophagy(GO:0010507) |
| 0.0 |
0.2 |
GO:0006013 |
mannose metabolic process(GO:0006013) |
| 0.0 |
0.2 |
GO:0019321 |
pentose metabolic process(GO:0019321) |
| 0.0 |
0.1 |
GO:0070493 |
thrombin receptor signaling pathway(GO:0070493) |
| 0.0 |
0.4 |
GO:0006582 |
melanin metabolic process(GO:0006582) |
| 0.0 |
2.1 |
GO:0034728 |
nucleosome organization(GO:0034728) |
| 0.0 |
0.1 |
GO:0006689 |
ganglioside catabolic process(GO:0006689) |
| 0.0 |
0.3 |
GO:0045646 |
regulation of erythrocyte differentiation(GO:0045646) |
| 0.0 |
0.0 |
GO:0009648 |
photoperiodism(GO:0009648) |
| 0.0 |
0.2 |
GO:0051973 |
positive regulation of telomerase activity(GO:0051973) |
| 0.0 |
0.5 |
GO:0008206 |
bile acid metabolic process(GO:0008206) |
| 0.0 |
0.9 |
GO:0060326 |
cell chemotaxis(GO:0060326) |
| 0.0 |
0.1 |
GO:0032729 |
positive regulation of interferon-gamma production(GO:0032729) |
| 0.0 |
0.6 |
GO:0006695 |
cholesterol biosynthetic process(GO:0006695) |
| 0.0 |
0.3 |
GO:0007603 |
phototransduction, visible light(GO:0007603) |
| 0.0 |
0.2 |
GO:0001662 |
behavioral fear response(GO:0001662) |
| 0.0 |
0.2 |
GO:0000185 |
activation of MAPKKK activity(GO:0000185) |
| 0.0 |
0.1 |
GO:0006655 |
phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
| 0.0 |
0.1 |
GO:0021854 |
hypothalamus development(GO:0021854) |
| 0.0 |
0.1 |
GO:0016265 |
obsolete death(GO:0016265) |
| 0.0 |
0.0 |
GO:0007097 |
nuclear migration(GO:0007097) |
| 0.0 |
0.4 |
GO:0018298 |
protein-chromophore linkage(GO:0018298) |
| 0.0 |
0.0 |
GO:0032011 |
ARF protein signal transduction(GO:0032011) |
| 0.0 |
0.1 |
GO:0003416 |
endochondral bone growth(GO:0003416) growth plate cartilage development(GO:0003417) bone growth(GO:0098868) |
| 0.0 |
0.5 |
GO:0051925 |
obsolete regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051925) |
| 0.0 |
0.1 |
GO:0009629 |
response to gravity(GO:0009629) |
| 0.0 |
0.4 |
GO:0050732 |
negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
| 0.0 |
0.1 |
GO:0035455 |
response to interferon-alpha(GO:0035455) |
| 0.0 |
0.1 |
GO:0021932 |
hindbrain radial glia guided cell migration(GO:0021932) |
| 0.0 |
0.1 |
GO:0032455 |
nerve growth factor processing(GO:0032455) |
| 0.0 |
0.1 |
GO:0033261 |
obsolete regulation of S phase(GO:0033261) |
| 0.0 |
1.0 |
GO:0019882 |
antigen processing and presentation(GO:0019882) |
| 0.0 |
0.2 |
GO:0045907 |
positive regulation of vasoconstriction(GO:0045907) |
| 0.0 |
0.2 |
GO:0008634 |
obsolete negative regulation of survival gene product expression(GO:0008634) |
| 0.0 |
0.1 |
GO:0061303 |
cornea development in camera-type eye(GO:0061303) |
| 0.0 |
0.1 |
GO:0048147 |
negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 |
0.1 |
GO:0033137 |
negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
| 0.0 |
0.1 |
GO:0006531 |
aspartate metabolic process(GO:0006531) aspartate catabolic process(GO:0006533) |
| 0.0 |
0.1 |
GO:0046464 |
neutral lipid catabolic process(GO:0046461) acylglycerol catabolic process(GO:0046464) |
| 0.0 |
0.1 |
GO:0050000 |
chromosome localization(GO:0050000) establishment of chromosome localization(GO:0051303) |
| 0.0 |
0.0 |
GO:0045347 |
negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.0 |
0.1 |
GO:0060689 |
cell differentiation involved in salivary gland development(GO:0060689) |
| 0.0 |
0.1 |
GO:0060760 |
positive regulation of response to cytokine stimulus(GO:0060760) |
| 0.0 |
1.1 |
GO:0006888 |
ER to Golgi vesicle-mediated transport(GO:0006888) |
| 0.0 |
0.1 |
GO:0017144 |
drug metabolic process(GO:0017144) |
| 0.0 |
0.0 |
GO:0034287 |
detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
| 0.0 |
0.1 |
GO:1903115 |
regulation of muscle filament sliding(GO:0032971) regulation of actin filament-based movement(GO:1903115) |
| 0.0 |
0.1 |
GO:0018410 |
C-terminal protein amino acid modification(GO:0018410) |
| 0.0 |
0.1 |
GO:0043985 |
histone H4-R3 methylation(GO:0043985) |
| 0.0 |
0.0 |
GO:0048302 |
isotype switching to IgG isotypes(GO:0048291) regulation of isotype switching to IgG isotypes(GO:0048302) positive regulation of isotype switching to IgG isotypes(GO:0048304) |
| 0.0 |
0.1 |
GO:0032057 |
negative regulation of translational initiation in response to stress(GO:0032057) |
| 0.0 |
0.4 |
GO:0006182 |
cGMP biosynthetic process(GO:0006182) |
| 0.0 |
0.1 |
GO:0015742 |
alpha-ketoglutarate transport(GO:0015742) |
| 0.0 |
0.1 |
GO:0050910 |
detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
| 0.0 |
0.1 |
GO:1902806 |
regulation of cell cycle G1/S phase transition(GO:1902806) regulation of G1/S transition of mitotic cell cycle(GO:2000045) |
| 0.0 |
0.1 |
GO:0031954 |
positive regulation of protein autophosphorylation(GO:0031954) |
| 0.0 |
0.0 |
GO:0016188 |
synaptic vesicle maturation(GO:0016188) |
| 0.0 |
1.3 |
GO:0046777 |
protein autophosphorylation(GO:0046777) |
| 0.0 |
0.0 |
GO:0008228 |
opsonization(GO:0008228) |
| 0.0 |
0.0 |
GO:0010677 |
negative regulation of cellular carbohydrate metabolic process(GO:0010677) |
| 0.0 |
0.5 |
GO:0006662 |
glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
| 0.0 |
0.2 |
GO:0019228 |
neuronal action potential(GO:0019228) |
| 0.0 |
1.2 |
GO:0006968 |
cellular defense response(GO:0006968) |
| 0.0 |
0.8 |
GO:0006749 |
glutathione metabolic process(GO:0006749) |
| 0.0 |
0.2 |
GO:0043113 |
receptor clustering(GO:0043113) |
| 0.0 |
0.1 |
GO:0043545 |
Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
| 0.0 |
0.1 |
GO:0015871 |
choline transport(GO:0015871) |
| 0.0 |
0.2 |
GO:0006621 |
protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
| 0.0 |
0.1 |
GO:0007215 |
glutamate receptor signaling pathway(GO:0007215) |
| 0.0 |
0.3 |
GO:0001522 |
pseudouridine synthesis(GO:0001522) |
| 0.0 |
0.1 |
GO:0009266 |
response to temperature stimulus(GO:0009266) |
| 0.0 |
0.6 |
GO:0090090 |
negative regulation of canonical Wnt signaling pathway(GO:0090090) |
| 0.0 |
0.0 |
GO:0002040 |
sprouting angiogenesis(GO:0002040) |
| 0.0 |
6.1 |
GO:0051056 |
regulation of small GTPase mediated signal transduction(GO:0051056) |
| 0.0 |
0.1 |
GO:0015791 |
polyol transport(GO:0015791) |
| 0.0 |
0.4 |
GO:0006284 |
base-excision repair(GO:0006284) |
| 0.0 |
0.0 |
GO:0001964 |
startle response(GO:0001964) |
| 0.0 |
0.1 |
GO:0045744 |
negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
| 0.0 |
0.0 |
GO:0007199 |
G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
| 0.0 |
0.1 |
GO:0034638 |
phosphatidylcholine catabolic process(GO:0034638) |
| 0.0 |
0.1 |
GO:0046689 |
response to mercury ion(GO:0046689) |
| 0.0 |
0.0 |
GO:0098781 |
ncRNA transcription(GO:0098781) |
| 0.0 |
0.1 |
GO:0043923 |
positive regulation by host of viral transcription(GO:0043923) |
| 0.0 |
0.2 |
GO:0030101 |
natural killer cell activation(GO:0030101) |
| 0.0 |
0.1 |
GO:0044341 |
sodium-dependent phosphate transport(GO:0044341) |
| 0.0 |
0.1 |
GO:0033169 |
histone H3-K9 demethylation(GO:0033169) |
| 0.0 |
0.1 |
GO:0009650 |
UV protection(GO:0009650) |
| 0.0 |
0.1 |
GO:0070207 |
protein homotrimerization(GO:0070207) |
| 0.0 |
0.2 |
GO:0030431 |
sleep(GO:0030431) |
| 0.0 |
0.6 |
GO:0051402 |
neuron apoptotic process(GO:0051402) |
| 0.0 |
2.3 |
GO:0043087 |
regulation of GTPase activity(GO:0043087) |
| 0.0 |
0.1 |
GO:0019372 |
lipoxygenase pathway(GO:0019372) |
| 0.0 |
0.1 |
GO:0006383 |
transcription from RNA polymerase III promoter(GO:0006383) |
| 0.0 |
0.1 |
GO:0048625 |
myoblast fate commitment(GO:0048625) |
| 0.0 |
0.1 |
GO:0006167 |
AMP biosynthetic process(GO:0006167) |
| 0.0 |
0.0 |
GO:0000212 |
meiotic spindle organization(GO:0000212) |
| 0.0 |
0.1 |
GO:0016073 |
snRNA metabolic process(GO:0016073) |
| 0.0 |
0.2 |
GO:0006044 |
N-acetylglucosamine metabolic process(GO:0006044) |
| 0.0 |
0.3 |
GO:0007528 |
neuromuscular junction development(GO:0007528) |
| 0.0 |
0.1 |
GO:0032799 |
low-density lipoprotein receptor particle metabolic process(GO:0032799) |
| 0.0 |
0.1 |
GO:0007422 |
peripheral nervous system development(GO:0007422) |
| 0.0 |
0.1 |
GO:0008625 |
extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.0 |
0.1 |
GO:0030010 |
establishment of cell polarity(GO:0030010) |
| 0.0 |
0.1 |
GO:0006893 |
Golgi to plasma membrane transport(GO:0006893) vesicle-mediated transport to the plasma membrane(GO:0098876) |
| 0.0 |
0.1 |
GO:0007320 |
insemination(GO:0007320) |
| 0.0 |
1.2 |
GO:0006119 |
oxidative phosphorylation(GO:0006119) |
| 0.0 |
0.1 |
GO:0021978 |
telencephalon regionalization(GO:0021978) |
| 0.0 |
0.1 |
GO:0006301 |
postreplication repair(GO:0006301) |
| 0.0 |
0.0 |
GO:0060596 |
mammary placode formation(GO:0060596) |
| 0.0 |
0.0 |
GO:0010259 |
multicellular organism aging(GO:0010259) |
| 0.0 |
0.0 |
GO:0051775 |
response to redox state(GO:0051775) |
| 0.0 |
0.2 |
GO:0006200 |
obsolete ATP catabolic process(GO:0006200) |
| 0.0 |
1.4 |
GO:0022900 |
electron transport chain(GO:0022900) |
| 0.0 |
0.1 |
GO:0048286 |
lung alveolus development(GO:0048286) |
| 0.0 |
0.1 |
GO:0018106 |
peptidyl-histidine phosphorylation(GO:0018106) |
| 0.0 |
0.0 |
GO:0002090 |
regulation of receptor internalization(GO:0002090) positive regulation of receptor internalization(GO:0002092) |
| 0.0 |
0.0 |
GO:0033522 |
histone H2A ubiquitination(GO:0033522) |
| 0.0 |
0.1 |
GO:0006349 |
regulation of gene expression by genetic imprinting(GO:0006349) |
| 0.0 |
0.0 |
GO:0007270 |
neuron-neuron synaptic transmission(GO:0007270) |
| 0.0 |
0.2 |
GO:0035264 |
multicellular organism growth(GO:0035264) |
| 0.0 |
0.0 |
GO:0006669 |
sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.0 |
0.0 |
GO:0060992 |
response to fungicide(GO:0060992) |
| 0.0 |
1.0 |
GO:0050954 |
sensory perception of mechanical stimulus(GO:0050954) |
| 0.0 |
0.3 |
GO:0006099 |
tricarboxylic acid cycle(GO:0006099) |
| 0.0 |
0.2 |
GO:0000060 |
protein import into nucleus, translocation(GO:0000060) |
| 0.0 |
0.1 |
GO:0002832 |
negative regulation of response to biotic stimulus(GO:0002832) |
| 0.0 |
0.0 |
GO:0070781 |
response to biotin(GO:0070781) |
| 0.0 |
0.0 |
GO:0051703 |
social behavior(GO:0035176) intraspecies interaction between organisms(GO:0051703) multi-organism behavior(GO:0051705) |
| 0.0 |
0.1 |
GO:0045663 |
positive regulation of myoblast differentiation(GO:0045663) |
| 0.0 |
0.8 |
GO:0006826 |
iron ion transport(GO:0006826) |
| 0.0 |
0.0 |
GO:0006930 |
substrate-dependent cell migration, cell extension(GO:0006930) |
| 0.0 |
0.1 |
GO:0032964 |
collagen biosynthetic process(GO:0032964) |
| 0.0 |
0.0 |
GO:0060968 |
regulation of gene silencing(GO:0060968) |
| 0.0 |
0.3 |
GO:0008380 |
RNA splicing(GO:0008380) |
| 0.0 |
0.2 |
GO:0030317 |
sperm motility(GO:0030317) |
| 0.0 |
0.1 |
GO:0001702 |
gastrulation with mouth forming second(GO:0001702) |
| 0.0 |
2.6 |
GO:0000375 |
RNA splicing, via transesterification reactions(GO:0000375) |
| 0.0 |
0.1 |
GO:0006265 |
DNA topological change(GO:0006265) |
| 0.0 |
0.2 |
GO:0008156 |
negative regulation of DNA replication(GO:0008156) |
| 0.0 |
0.2 |
GO:0007051 |
spindle organization(GO:0007051) |
| 0.0 |
0.0 |
GO:0018076 |
N-terminal peptidyl-lysine acetylation(GO:0018076) |
| 0.0 |
1.1 |
GO:0007218 |
neuropeptide signaling pathway(GO:0007218) |
| 0.0 |
0.0 |
GO:0071459 |
protein localization to chromosome, centromeric region(GO:0071459) |
| 0.0 |
0.4 |
GO:0007224 |
smoothened signaling pathway(GO:0007224) |
| 0.0 |
0.3 |
GO:0008203 |
cholesterol metabolic process(GO:0008203) |
| 0.0 |
0.0 |
GO:0007144 |
female meiosis I(GO:0007144) |
| 0.0 |
0.5 |
GO:0008630 |
intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
| 0.0 |
0.1 |
GO:0006536 |
glutamate metabolic process(GO:0006536) |
| 0.0 |
0.5 |
GO:0030071 |
regulation of mitotic metaphase/anaphase transition(GO:0030071) regulation of metaphase/anaphase transition of cell cycle(GO:1902099) |
| 0.0 |
0.1 |
GO:0060762 |
regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
| 0.0 |
0.5 |
GO:0009408 |
response to heat(GO:0009408) |
| 0.0 |
2.6 |
GO:0016568 |
chromatin modification(GO:0016568) |
| 0.0 |
0.1 |
GO:0070542 |
response to fatty acid(GO:0070542) |
| 0.0 |
0.0 |
GO:2000398 |
regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
| 0.0 |
0.1 |
GO:0031000 |
response to caffeine(GO:0031000) |
| 0.0 |
0.0 |
GO:0034126 |
regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034124) positive regulation of MyD88-dependent toll-like receptor signaling pathway(GO:0034126) |
| 0.0 |
0.5 |
GO:0000236 |
mitotic prometaphase(GO:0000236) |
| 0.0 |
0.3 |
GO:0006271 |
DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.0 |
0.1 |
GO:0007281 |
germ cell development(GO:0007281) |
| 0.0 |
0.2 |
GO:0007597 |
blood coagulation, intrinsic pathway(GO:0007597) |
| 0.0 |
0.0 |
GO:0005978 |
glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
| 0.0 |
0.1 |
GO:0002831 |
regulation of response to biotic stimulus(GO:0002831) |
| 0.0 |
0.1 |
GO:0015919 |
peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
| 0.0 |
0.0 |
GO:0003151 |
outflow tract morphogenesis(GO:0003151) |
| 0.0 |
0.0 |
GO:0006428 |
isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.0 |
1.6 |
GO:0031018 |
endocrine pancreas development(GO:0031018) |
| 0.0 |
0.2 |
GO:0051865 |
protein autoubiquitination(GO:0051865) |
| 0.0 |
0.1 |
GO:0001539 |
cilium or flagellum-dependent cell motility(GO:0001539) |
| 0.0 |
0.0 |
GO:0030279 |
negative regulation of ossification(GO:0030279) |
| 0.0 |
0.0 |
GO:0032508 |
DNA duplex unwinding(GO:0032508) |
| 0.0 |
0.0 |
GO:0060644 |
mammary gland epithelial cell differentiation(GO:0060644) |
| 0.0 |
0.1 |
GO:0070304 |
positive regulation of stress-activated MAPK cascade(GO:0032874) positive regulation of stress-activated protein kinase signaling cascade(GO:0070304) |
| 0.0 |
0.5 |
GO:0034339 |
obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
| 0.0 |
0.1 |
GO:0042255 |
ribosome assembly(GO:0042255) |
| 0.0 |
0.1 |
GO:0001954 |
positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.0 |
0.0 |
GO:0009134 |
nucleoside diphosphate catabolic process(GO:0009134) ribonucleoside diphosphate catabolic process(GO:0009191) |
| 0.0 |
0.0 |
GO:0042249 |
establishment of planar polarity of embryonic epithelium(GO:0042249) |
| 0.0 |
0.0 |
GO:0060084 |
synaptic transmission involved in micturition(GO:0060084) |
| 0.0 |
0.6 |
GO:0006352 |
DNA-templated transcription, initiation(GO:0006352) |
| 0.0 |
0.0 |
GO:0048664 |
neuron fate determination(GO:0048664) |
